Clinical Report: Perception and Acceptance of Fecal Microbiota Transplantation in Ethiopia

Overview

This qualitative study explored the acceptability of fecal microbiota transplantation (FMT) among patients, caregivers, and healthcare professionals (HCPs) in Addis Ababa, Ethiopia. Findings indicate general willingness among HCPs to prescribe FMT if supported by evidence, while patient acceptance ranged from unconvinced to accepting salvage treatment. Interventions are needed to enhance acceptance, including health communication and endorsement by community leaders.

Background

Malnutrition and antimicrobial-resistant infections are significant causes of morbidity and mortality in low-income countries and are linked to gut microbiome dysbiosis. FMT, involving transfer of fecal microbial communities from healthy donors, shows promise as a therapeutic intervention for these conditions. Despite its potential, little is known about the acceptability of FMT in low-income settings such as Ethiopia. Understanding perceptions among patients and healthcare providers is critical to facilitate translation and uptake of microbiota therapies in these contexts.

Data Highlights

The study conducted eight focus group discussions with 59 participants, including patients with bacterial infections, caregivers of malnourished children, and healthcare professionals from two major hospitals in Addis Ababa. Saturation of themes was achieved after three FGDs in both patient and HCP groups. Participants expressed varying levels of knowledge and acceptance of FMT, with healthcare providers generally willing to consider FMT pending evidence of safety and efficacy.

Key Findings

• Healthcare professionals showed general willingness to prescribe FMT if efficacy and safety are demonstrated and patient adherence is ensured.
• Patient acceptability of FMT existed on a continuum: unconvinced, persuadable, amenable, and accepting salvage treatment.
• Barriers to acceptance included limited knowledge, cultural perceptions, and concerns about the nature of the treatment.
• Facilitators for acceptance included marketing FMT as a standard medication and endorsement by religious leaders.
• Multiple formulations and thoughtful health communication strategies were suggested to improve uptake.
• There is a lack of prior research on microbiome composition and FMT acceptability in Ethiopia and other low-income countries.

Clinical Implications

Clinicians should consider educational interventions to improve patient and caregiver understanding of FMT, addressing cultural and perceptual barriers. Engagement with community and religious leaders may enhance acceptance. Further research and evidence generation on FMT safety and efficacy in local contexts are essential to support clinical adoption.

Conclusion

FMT may be an acceptable therapeutic option for antimicrobial-resistant infections and malnutrition in Ethiopia, but targeted strategies are needed to increase acceptance among patients and healthcare providers. This study provides foundational insights to guide implementation of microbiota therapies in low-income settings.

References

1. Study Authors/2024 -- Understanding the Perception and Acceptance of Fecal Microbiota Transplantation Among Patients, Caregivers, and Healthcare Professionals in Ethiopia